Meredith R. Golomb
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Meredith R. Golomb has a total of 533 co-authors. Here are the top co-authors by number of shared publications:
Bhuwan P. Garg
From the Division of Pediatric Neurology, Department of Neurology (J.A.Z., B.P.G., M.R.G.), and Department of Neuroradiology (D.P.O.), Indiana University School of Medicine, Indianapolis
20 shared publicationsLinda S. Williams
Regenstrief Institute, Indiana University School of Medicine, Indianapolis, Indiana
18 shared publicationsLaurence E. Walsh
8 shared publicationsChandan Saha
Division of Biostatistics, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana
7 shared publicationsDaune L. MacGregor
7 shared publicationsGabrielle A. Deveber
7 shared publications
Latest Publications
- 1 March 2023
- Published by SAGE Publications in Journal of Child Neurology
- Vol. 38 (3-4) , 142-152
A Standardized, 3-Tiered, Seizure Burden–Based Protocol for the Treatment of Neonatal Seizures
Objective: To evaluate use of a standardized, 3-tiered, seizure burden-based protocol for treatment of all electroencephalography (EEG)-confirmed seizures in a level IV neonatal intensive care unit (NICU). Study Design: All infants admitted to the NICU with EEG-confirmed seizures over a 25-month period were enrolled in the study. We compared short-term outcomes before and after implementation of a standardized, 3-tiered protocol. Results: A total of 107 infants were enrolled in the study. Use of midazolam infusions was reduced by 53.7% ( p = 0.02). Midazolam infusion duration increased from 4 to 7.5 days ( p = 0.003); however, when excluding 3 outliers, there was no significant difference between groups ( p = 0.67). Duration of EEG monitoring decreased from 5 to 3 days ( p = 0.005). Hospital length of stay was unchanged. Conclusion: Implementation of a standardized, 3-tiered protocol for treatment of neonatal seizures improved short-term outcomes. Although not measured directly, reductions in EEG duration and midazolam use are promising indicators of overall seizure burden. More research is needed to evaluate impact on long-term neurodevelopmental outcomes.
- 1 March 2023
- Published by SAGE Publications in Journal of Child Neurology
- Vol. 38 (3-4) , 142-152
A Standardized, 3-Tiered, Seizure Burden–Based Protocol for the Treatment of Neonatal Seizures
Objective: To evaluate use of a standardized, 3-tiered, seizure burden-based protocol for treatment of all electroencephalography (EEG)-confirmed seizures in a level IV neonatal intensive care unit (NICU). Study Design: All infants admitted to the NICU with EEG-confirmed seizures over a 25-month period were enrolled in the study. We compared short-term outcomes before and after implementation of a standardized, 3-tiered protocol. Results: A total of 107 infants were enrolled in the study. Use of midazolam infusions was reduced by 53.7% ( p = 0.02). Midazolam infusion duration increased from 4 to 7.5 days ( p = 0.003); however, when excluding 3 outliers, there was no significant difference between groups ( p = 0.67). Duration of EEG monitoring decreased from 5 to 3 days ( p = 0.005). Hospital length of stay was unchanged. Conclusion: Implementation of a standardized, 3-tiered protocol for treatment of neonatal seizures improved short-term outcomes. Although not measured directly, reductions in EEG duration and midazolam use are promising indicators of overall seizure burden. More research is needed to evaluate impact on long-term neurodevelopmental outcomes.
- Open Access
- 1 January 2023
- Published by SAGE Publications in Child Neurology Open
- Vol. 10
A 2-Year-Old Child with Alazami Syndrome with Newly Reported Findings of Immune Deficiency, Periventricular Nodular Heterotopia, and Stroke; Broadening the Phenotype of Alazami
Alazami syndrome is a rare autosomal recessive neurodevelopmental disorder due to loss-of-function variants in the La ribonucleoprotein 7 (LARP7) gene. Children with Alazami syndrome are most often affected by a combination of primordial dwarfism, intellectual disability, and distinctive facial features. Previous cases have been primarily found in consanguineous families from the Middle East, Asia, and North Africa. We present a 21-month-old Caucasian male from the Midwest United States with nonconsanguineous parents who presented with frequently reported findings of unusual facial features, poor growth, cardiac and genitourinary findings, and developmental delay; less-frequently reported findings, including transient erythroblastopenia of childhood (TEC) and immune deficiency; and never-before reported findings of periventricular nodular heterotopia and stroke. He developed stroke during a hospitalization for Hemophilus influenzae meningitis. The possible contributions of LARP7 to TEC, immune deficiency, brain malformation, and stroke are discussed. Guidelines for the care of Alazami patients are proposed.
- 1 January 2023
- Published by SAGE Publications in Child Neurology Open
- Vol. 10
Open AccessA 2-Year-Old Child with Alazami Syndrome with Newly Reported Findings of Immune Deficiency, Periventricular Nodular Heterotopia, and Stroke; Broadening the Phenotype of Alazami
Alazami syndrome is a rare autosomal recessive neurodevelopmental disorder due to loss-of-function variants in the La ribonucleoprotein 7 (LARP7) gene. Children with Alazami syndrome are most often affected by a combination of primordial dwarfism, intellectual disability, and distinctive facial features. Previous cases have been primarily found in consanguineous families from the Middle East, Asia, and North Africa. We present a 21-month-old Caucasian male from the Midwest United States with nonconsanguineous parents who presented with frequently reported findings of unusual facial features, poor growth, cardiac and genitourinary findings, and developmental delay; less-frequently reported findings, including transient erythroblastopenia of childhood (TEC) and immune deficiency; and never-before reported findings of periventricular nodular heterotopia and stroke. He developed stroke during a hospitalization for Hemophilus influenzae meningitis. The possible contributions of LARP7 to TEC, immune deficiency, brain malformation, and stroke are discussed. Guidelines for the care of Alazami patients are proposed.
- 11 February 2022
- Published by Elsevier in Pediatric Neurology
- Vol. 130, 1-3
Acute and Delayed Cerebrovascular Injury From Gunshot to the Head in a 12-Year-Old Child During the COVID-19 Pandemic
- 11 February 2022
- Published by Elsevier in Pediatric Neurology
- Vol. 130, 1-3
Acute and Delayed Cerebrovascular Injury From Gunshot to the Head in a 12-Year-Old Child During the COVID-19 Pandemic
- 1 January 2022
- Published by Elsevier in Pediatric Neurology
- Vol. 126, 89-93
Fetal Cerebral Sinovenous Thrombosis and Dural Sinus Malformation
- 1 January 2022
- Published by Elsevier in Pediatric Neurology
- Vol. 126, 89-93
Fetal Cerebral Sinovenous Thrombosis and Dural Sinus Malformation
- 12 January 2021
- Published by Wolters Kluwer Health in Neurology
- Vol. 96 (2) , 78
Technical Difficulties in the Time of COVID
- 12 January 2021
- Published by Wolters Kluwer Health in Neurology
- Vol. 96 (2) , 78
Technical Difficulties in the Time of COVID
- Open Access
- 1 January 2021
- Published by SAGE Publications in Child Neurology Open
- Vol. 8
Patients With Extreme Early Onset Juvenile Huntington Disease Can Have Delays in Diagnosis: A Case Report and Literature Review
Huntington disease (HD) is caused by a pathologic cytosine-adenine-guanine (CAG) trinucleotide repeat expansion in the HTT gene. Typical adult-onset disease occurs with a minimum of 40 repeats. With more than 60 CAG repeats, patients can have juvenile-onset disease (jHD), with symptom onset by the age of 20 years. We report a case of a boy with extreme early onset, paternally inherited jHD, with symptom onset between 18 and 24 months. He was found to have 250 to 350 CAG repeats, one of the largest repeat expansions published to date. At initial presentation, he had an ataxic gait, truncal titubation, and speech delay. Magnetic resonance imaging showed cerebellar atrophy. Over time, he continued to regress and became nonverbal, wheelchair-bound, gastrostomy-tube dependent, and increasingly rigid. His young age at presentation and the ethical concerns regarding HD testing in minors delayed his diagnosis.
- 1 January 2021
- Published by SAGE Publications in Child Neurology Open
- Vol. 8
Open AccessPatients With Extreme Early Onset Juvenile Huntington Disease Can Have Delays in Diagnosis: A Case Report and Literature Review
Huntington disease (HD) is caused by a pathologic cytosine-adenine-guanine (CAG) trinucleotide repeat expansion in the HTT gene. Typical adult-onset disease occurs with a minimum of 40 repeats. With more than 60 CAG repeats, patients can have juvenile-onset disease (jHD), with symptom onset by the age of 20 years. We report a case of a boy with extreme early onset, paternally inherited jHD, with symptom onset between 18 and 24 months. He was found to have 250 to 350 CAG repeats, one of the largest repeat expansions published to date. At initial presentation, he had an ataxic gait, truncal titubation, and speech delay. Magnetic resonance imaging showed cerebellar atrophy. Over time, he continued to regress and became nonverbal, wheelchair-bound, gastrostomy-tube dependent, and increasingly rigid. His young age at presentation and the ethical concerns regarding HD testing in minors delayed his diagnosis.
- 1 December 2020
- Published by Elsevier in The Journal of Pediatrics
- Vol. 227, 318-319
An Infant Presenting with Large, Asymmetric Tongue
- 1 December 2020
- Published by Elsevier in The Journal of Pediatrics
- Vol. 227, 318-319
An Infant Presenting with Large, Asymmetric Tongue
- 1 August 2020
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 29 (8) , 104939
Neurological issues in COVID-19, summarized in verse
- 1 August 2020
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 29 (8) , 104939
Neurological issues in COVID-19, summarized in verse
- 1 July 2020
- Published by Wolters Kluwer Health in Stroke
- Vol. 51 (7) , E138
Letter by Golomb and Hall Regarding Article, “Temporary Emergency Guidance to US Stroke Centers During the COVID-19 Pandemic”
- 1 July 2020
- Published by Wolters Kluwer Health in Stroke
- Vol. 51 (7) , E138
Letter by Golomb and Hall Regarding Article, “Temporary Emergency Guidance to US Stroke Centers During the COVID-19 Pandemic”
- 8 June 2020
- Published by SAGE Publications in Journal of Child Neurology
- Vol. 35 (11) , 767-772
Bow Hunter’s Syndrome in Children: A Review of the Literature and Presentation of a New Case in a 12-Year-Old Girl
Background: Bow hunter's syndrome, or occlusion of the vertebral artery with head rotation leading to ischemia and sometimes stroke, is rarely described in children. The authors review the literature and present a new case. Methods: Both OVID dating back to 1946 and PubMed records were reviewed using the terms (“Bow hunter syndrome” OR “bow hunter’s”) OR “rotational vertebral artery occlusion” combined with “child,” and limited to English language. SCOPUS and the bibliographies of cases found in the search were used to identify additional articles. Results: Twelve articles were found describing 25 patients; there were 26 patients when combined with our case. Ages ranged from 1 to 18 years. Most (88.5%, 23/26) were male. Medical treatments included aspirin, clopidogrel, abciximab, enoxaparin, warfarin, and cervical collar. Stenting was tried in 2 cases but did not work long-term. Surgical treatments included decompression, cervical fusion, or a combination. We present a new case of a 12-year-old girl with recurrent stroke who had bilateral vascular compression only visible on provocative angiographic imaging with head turn. She was referred for cervical fusion, and abnormal ligamentous laxity was noted intraoperatively. Conclusions: Bow hunter's syndrome is a rare but important cause of stroke since many of the patients experience recurrent strokes before the diagnosis is made. Reasons for the male predominance are unclear. Provocative angiography plays a key role in diagnosis, and both medical treatment and neurosurgical intervention may prevent recurrence.
- 8 June 2020
- Published by SAGE Publications in Journal of Child Neurology
- Vol. 35 (11) , 767-772
Bow Hunter’s Syndrome in Children: A Review of the Literature and Presentation of a New Case in a 12-Year-Old Girl
Background: Bow hunter's syndrome, or occlusion of the vertebral artery with head rotation leading to ischemia and sometimes stroke, is rarely described in children. The authors review the literature and present a new case. Methods: Both OVID dating back to 1946 and PubMed records were reviewed using the terms (“Bow hunter syndrome” OR “bow hunter’s”) OR “rotational vertebral artery occlusion” combined with “child,” and limited to English language. SCOPUS and the bibliographies of cases found in the search were used to identify additional articles. Results: Twelve articles were found describing 25 patients; there were 26 patients when combined with our case. Ages ranged from 1 to 18 years. Most (88.5%, 23/26) were male. Medical treatments included aspirin, clopidogrel, abciximab, enoxaparin, warfarin, and cervical collar. Stenting was tried in 2 cases but did not work long-term. Surgical treatments included decompression, cervical fusion, or a combination. We present a new case of a 12-year-old girl with recurrent stroke who had bilateral vascular compression only visible on provocative angiographic imaging with head turn. She was referred for cervical fusion, and abnormal ligamentous laxity was noted intraoperatively. Conclusions: Bow hunter's syndrome is a rare but important cause of stroke since many of the patients experience recurrent strokes before the diagnosis is made. Reasons for the male predominance are unclear. Provocative angiography plays a key role in diagnosis, and both medical treatment and neurosurgical intervention may prevent recurrence.